Simcere Pharmaceutical Group Limited (HKG:2096)
13.62
+0.10 (0.74%)
Apr 2, 2026, 4:08 PM HKT
HKG:2096 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,512 | 1,943 | 2,007 | 1,658 | 973.14 |
Short-Term Investments | 65.53 | - | 11.14 | 964.23 | 1,210 |
Cash & Short-Term Investments | 3,578 | 1,943 | 2,018 | 2,623 | 2,183 |
Cash Growth | 84.12% | -3.73% | -23.04% | 20.12% | -33.31% |
Accounts Receivable | 2,858 | 2,704 | 2,645 | 2,339 | 2,399 |
Other Receivables | 4.74 | 60.06 | 50.73 | 39.89 | 37.37 |
Receivables | 2,963 | 2,764 | 2,695 | 2,379 | 2,436 |
Inventory | 589.5 | 683.97 | 770.14 | 371.59 | 290.96 |
Other Current Assets | 259.79 | 74.21 | 155.13 | 85.61 | 69.24 |
Total Current Assets | 7,390 | 5,466 | 5,639 | 5,458 | 4,980 |
Property, Plant & Equipment | 2,532 | 2,270 | 2,170 | 2,139 | 1,931 |
Long-Term Investments | 2,352 | 1,893 | 1,580 | 2,258 | 2,651 |
Goodwill | 142.47 | 142.47 | 142.47 | 172.79 | 172.79 |
Other Intangible Assets | 1,443 | 1,025 | 715.79 | 379.9 | 59.69 |
Long-Term Deferred Tax Assets | 520.71 | 435.59 | 317 | 326.71 | 289.97 |
Other Long-Term Assets | 346.03 | 178.19 | 188.95 | 53.79 | 76.56 |
Total Assets | 14,726 | 11,510 | 10,854 | 10,789 | 10,161 |
Accounts Payable | 249.03 | 275.73 | 317.22 | 335.43 | 323.95 |
Accrued Expenses | 999.22 | 1,031 | 1,045 | 1,124 | 1,032 |
Short-Term Debt | 1,052 | 1,050 | 762.43 | 1,184 | 991.57 |
Current Portion of Long-Term Debt | 0.7 | 0.72 | 252.71 | 108.37 | 538.51 |
Current Portion of Leases | 57.34 | 67.56 | 79.85 | 58.76 | 31.56 |
Current Income Taxes Payable | 65.7 | 154.36 | 17.9 | 10.56 | 16.16 |
Current Unearned Revenue | 687.06 | 28.16 | 43.31 | 63.34 | 26.14 |
Other Current Liabilities | 234.22 | 119.25 | 167 | 82.41 | 103.7 |
Total Current Liabilities | 3,345 | 2,727 | 2,686 | 2,967 | 3,064 |
Long-Term Debt | 7.48 | 8.25 | 205.85 | - | - |
Long-Term Leases | 69.64 | 82.42 | 128.4 | 155.92 | 74.24 |
Long-Term Unearned Revenue | 472.53 | 377.69 | 393.11 | 403.35 | 417.61 |
Long-Term Deferred Tax Liabilities | 68.04 | 72.7 | 102.68 | 115.29 | 142.77 |
Other Long-Term Liabilities | 1,348 | 1,174 | 115 | - | - |
Total Liabilities | 5,311 | 4,442 | 3,631 | 3,641 | 3,698 |
Common Stock | 4,619 | 3,174 | 3,174 | 3,081 | 3,003 |
Retained Earnings | - | 3,481 | 3,837 | 3,831 | 3,294 |
Comprehensive Income & Other | 4,789 | 413.29 | 211.61 | 219.72 | 139.96 |
Total Common Equity | 9,408 | 7,068 | 7,223 | 7,132 | 6,437 |
Minority Interest | 6.72 | - | - | 16.06 | 25.76 |
Shareholders' Equity | 9,415 | 7,068 | 7,223 | 7,148 | 6,463 |
Total Liabilities & Equity | 14,726 | 11,510 | 10,854 | 10,789 | 10,161 |
Total Debt | 1,187 | 1,209 | 1,429 | 1,507 | 1,636 |
Net Cash (Debt) | 2,391 | 733.7 | 589.08 | 1,116 | 547.34 |
Net Cash Growth | 225.84% | 24.55% | -47.21% | 103.86% | - |
Net Cash Per Share | 0.96 | 0.29 | 0.23 | 0.43 | 0.21 |
Filing Date Shares Outstanding | 2,519 | 2,486 | 2,617 | 2,660 | 2,628 |
Total Common Shares Outstanding | 2,519 | 2,486 | 2,617 | 2,660 | 2,628 |
Working Capital | 4,045 | 2,739 | 2,953 | 2,492 | 1,916 |
Book Value Per Share | 3.74 | 2.84 | 2.76 | 2.68 | 2.45 |
Tangible Book Value | 7,823 | 5,900 | 6,364 | 6,579 | 6,205 |
Tangible Book Value Per Share | 3.11 | 2.37 | 2.43 | 2.47 | 2.36 |
Machinery | - | 2,961 | 2,632 | 2,811 | 2,528 |
Construction In Progress | - | 343.38 | 343.47 | 202.13 | 95.75 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.